Resistance to penicillin and other antimicrobials in 301 clinical isolates of Streptococcus pneumoniae;Resistencia a penicilina y otros antimicrobianos en 301 aislamientos clínicos de Streptococcus pneumoniae

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 18, Issue 7, 2000, Pages 314-318

  Navarro, Carmen ^a,c   Egido, Pilar ^a   Aspiroz, Carmen ^a   Durán, Estrella ^b   García, Concepción ^b   Rubio, Carmen ^b   Gómez Lus, Rafael ^b  

^a Hospital de Alcañiz Alcañiz   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c Hospital de Alcañiz   (Spain)

Author keywords

Cephalosporins; Penicillin; Resistance; Streptococus pneumoniae; Susceptibility to antimicrobials

Indexed keywords

CEFEPIME; CEFIXIME; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; OXACILLIN; PENICILLIN G; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; CHILD; CHLORAMPHENICOL; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE; TETRACYCLINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0034489234     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Liñares J, Pallarés R. Alonso T, Pérez JL, Ayats J, Gudiol F et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992; 15: 99-105.
2. García-Martos P, Galán F, Marín P, Mira J. Increase in high resistance to penicillin of clinical isolates of Streptococus pneumoniae in Cádiz, Spain. Chemotherapy 1997; 43: 179-181.
3. Colom K, Fernández-Aranguiz A, Alonso R, Cisterna R. Five-year survey of cefotaxime resistance in Spain. Microb Drug Resist 1995; 1: 327-330.
4. Liñares J, Tubau F. Resistencia a cefalosporinas en infecciones por Streptococcus pneumoniae. Med Clin (Barc) 1998; 110 (Supl 1): 21-24.
5. Catalán MJ, Fernández JM, Vázquez A, Varela de Seijas E, Suárez A, Bernaldo de Quirós JC. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis 1994; 18: 766-769.
6. Fenoll A, Jado I, Vicioso D, Pérez A, Casal J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol 1998; 36: 3447-3454.
7. Alonso-Manzanares MA, Gutiérrez-Zafiaurre MN, Muñoz-Bellido JJ, García-Rodríguez JA. Resistencia a macrólidos, lincosamidas y estreptograminas en infecciones por Streptococcus pneumoniae. Med Clin (Barc) 1998; 110 (Supl 1): 25-30.
8. National Committee for Clinical Laboratory standards: Methods for dilution antimicrobial susceptibility test for that grow aerobically. Approved standard M100-S7 NCCLS, Vilanova, PA, 1997.
9. National Committee for Clinical Laboratory standards: Methods performance standards for antimicrobial disk susceptibility test. Approved standard M100-S5.NCCLS, Vilanova, PA, 1997.
10. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967; 2: 264-265.
11. Appelbaum PC, Bhamjee A, Scragg JN, Hallett AF, Bowen AJ, Cooper RC. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977; 2: 995-997.
12. Jacobs MR, Koornhof HJ, Robins-Browne RM, Stevenson CM, Vermaak ZA, Freiman I et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978; 299: 735-40.
13. Lee HJ, Park JY, Jang SH, Kim JH, Kim EC, Choi KW. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university in Korea. Clin Infect Dis 1995; 20: 826-835.
14. Marton A. Epidemiology of resistant pneumococci in Hungary. Microb Drug Resist 1995; 1: 127-130.
15. Pana M, Ungureanu V, Mihalcu F, Verenau A, Stanescu C. Study of resistant pneumococci in Romania between 1973-1995. Adv Exp Med Biol 1997; 418: 471-473.
16. Liñares J, Tubau F, Alcaide F, Ardanuy C, García A, Martín R. Antimicrobial resistance of Streptococcus pneumoniae: comparison of the in vitro activity of 16 antibiotics. Current Therapeutic Research 1996; 57 (Supl A): 57-64.
17. Ramos JT, Saavedra J, Ruiz-Contreras J, Bravo J, Sanz F, Noriega AR. Invasive antibiotic-resistant Streptococcus pneumoniae in children in Madrid. Pediatr Infect Dis J 1998; 17: 252-255.
18. Baquero F, García-Rodríguez JA, García de Lomas J, Aguilar L, y el Grupo Español de Vigilancia de Patógenos Respiratorios. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain. Results of a 1-year (1996-1997) multicenter surveillance study. Antimicrob Agents Chemother 1999; 43: 357-359.
19. Geslin P, Fremaux A, Sissia G. Epidémiologie de la résistance aux antibiotiques de Streptococcus pneumoniae. Arch Pédiatr 1996; 3 (Supl 1): 93-95.
20. Liñares J, Alonso T, Pérez JL, Ayats J, Domínguez MA, Pallarés R et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J Antimicrob Chemother 1992; 30: 279-288.
21. Fenoll A, Bourgon CM, Muñoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991; 13: 56-60.
22. Aszkenasy OM, George RC, Begg NT. Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992. CDR 1995; 5: R45-R50.
23. García de Lomas J, Gimeno C, Millás E, Bermejo M, Lázaro MA, Navarro D et al. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain. Eur J Clin Microbiol Infect Dis 1997; 16: 11-13.
24. Pak-Leung Ho, Tak-Lun Que, Dominic Ngai-Chong Tsang, Tak-Keung Ng, Kin-Hung Chow, Wing-Hon Seto. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother 1999; 43: 1310-1313.
25. Pontani D, Washton H, Bouchillon S, Johnson J. Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicilin. Eur J Clin Microbiol Infect Dis 1998; 17: 413-419.
26. Felmingham D, Robbins MJ, Tesfaslasie Y, Harding I, Shrimpton S, Grüneberg RN. Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season. J Antimicrob Chemother 1998; 41: 411-415.
27. Blondeau JM, Suter M, Borsos S. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group. J Antimicrob Chemother 1999; 43 (Supl A): 25-30.
28. Thornsberry C, Ogilvie PT, Holley HP Jr, Sahm DF. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Antimicrob Agents Chemother 1999; 43: 2612-2623.
29. Hofman J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliot JA et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333: 481-486.
30. Thornsberry C, Burton PH, Vanderhoof BH. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study. Diagn Microbiol Infect Dis 1996; 25: 89-95.
31. Kessler RE, Bies M, Buck RE, Chisholm DR, Pursiano TA, Tsai YH et al. Comparison of a new cephalosporin, BMY 28142, with other broad spectrum β-lactam antibiotics. Antimicrob Agents Chemother 1985; 27: 207-216.
32. Bodey GP, Dahhsi H, Leblanc B. In vitro studies of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother 1985; 27: 265-269.
33. Vuye A, Pijck J. In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin. Antimicrob Agents Chemother 1985; 27: 574-577.
34. Yee YC, Thornsberry C, Brown SD, Bouchillon SK, Marler JK, Rich T. A comparative study of the in-vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 1993; 32 (Supl B): 13-19.
35. Kessler RE, Fung-Tomc J. Susceptibility of bacterial isolates to β-lactam antibiotics from U.S. clinical trials over a 5-year period. Am J Med 1996; 100 (Supl 6): 13-19.
36. Spangler SK, Jacobs MR, Appelbaum C. Susceptibilities of 177 penicillin-susceptible and resistant pneumococci to FK037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem and vancomycin. Antimicrob Agents Chemother 1994; 38: 898-900.
37. Martínez-Beltrán J, Cantón R, Liñares J, García de Lomas J, Gimeno C, Tubau F et al. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin. Eur J Clin Microb Infect Dis 1995; 14: 244-252.
38. Knudsen JD, Fuursted K, Frimodt-Moller N, Espersen F. Comparison of the effect of cefepime with four cephalosporins against pneumococci with various susceptibilities to penicillin, in vitro and in the mouse peritonitis model. J Antimicrob Chemother 1997; 40: 679-686.
39. Guillemot D, Carbon C, Balkau B, Geslin P, Lecoeur H, Vauzelle-Keervroẽdan F et al. Low dosage and long treatment duration of beta-lactam. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998; 279: 365-370.
40. Gómez-Lus R, Adrián F, Gómez-Lus S, Rubio-Calvo MC. Presión selectiva antibiótica y resistencia en infecciones por Streptococcus pneumoniae. Med Clin (Barc) 1998; 110 (Supl 1): 3-7.